From Product Launches To Toll Manufacturing, Japanese Giant Takeda Unveils Plans For India
This article was originally published in PharmAsia News
MUMBAI - Almost a year after naming former Roche executive Shankar Suryanarayanan as head of its Indian operations, Japan's largest drug maker Takeda has unveiled "medium- to long-term strategies" for its business expansion - one of which is to launch its products in the burgeoning Indian market
You may also be interested in...
For the past four years, Takeda’s plans for a full-scale entry into India have remained just that – plans on paper. But will it be a laggard for much longer in this fast-changing key emerging market? There are signs that the time may now be ripe for Japan’s top pharma firm to take a more decisive plunge.
Takeda’s plans for India are slowly taking shape, but whether it will gain speed via buyouts or go the brick- and-mortar route is the big question.
Takeda looks to ride on Advinus’ broad early-stage pipeline while also generating new INDs.